Study on the Level of Physical Activity in Patients Diagnosed With Breast Cancer in Spain

NCT07478939 | Completed

• 1 other identifier: GEICAM/2021-05
• Study Type: observational
• Target: 507
• Locations: 1 country
• Sites: 1

Brief Summary

There is strong evidence demonstrating the benefits that physical activity (PA) provides for patients with breast cancer (BC), both in prevention and throughout various treatments and in survivorship. However, there is still very limited information available regarding the level or amount of PA undertaken by BC patients or survivors. On the other hand, although there are general recommendations for physical exercise- 150-300 minutes per week of moderate activity or 75-150 minutes per week of vigorous activity-the type of physical exercise that is best at each stage of the disease, as well as adherence and preferences for different exercise programs, has not been thoroughly studied. Physical exercise is a healthy, easily implemented and low-cost intervention that ought to be much more widely adopted among the BC population. Understanding all these factors will help us better assess the degree of implementation and compliance with exercise programs in our population of BC patients. This diagnosis will be the first step towards establishing new strategies to improve patients' PA levels and their adherence to exercise programs, ultimately ensuring that these changes become consolidated as new lifestyle habits that provide our patients with a preventive factor against relapses, as well as a better quality of life.

Conditions

Breast Cancer

Keywords

breast cancer; physical activity; Spain; exercise; preferences; behaviour

Outcome Measures

Primary Outcomes (1)

• To analyze the level of physical activity (PA) of Spanish patients diagnosed with breast cancer (BC) through self-administered questionnaires

  The primary objective is assessed using the International Physical Activity Questionnaire (IPAQ). This questionnaire is a standardized instrument for measuring physical activity levels over the previous seven days. The long form comprises 27 to 31 detailed items covering work, transportation, household tasks, gardening, and leisure activities, with results classified in metabolic equivalents (METs) to categorize activity as low, moderate, or high. The questions are based on the number of days per week participants engage in specific physical activities and the duration of each activity.

  Day 1

Secondary Outcomes (5)

• Ascertain the preferences of Spanish patients diagnosed with breast cancer regarding physical exercise programs

  Day 1

• Assess sociodemographic differences in physical activity levels and references concerning physical exercise programs

  Day 1

• Evaluate differences in physical activity levels in relation to breast cancer treatment

  Day 1

• Assess the influence of breast cancer diagnosis on physical activity levels and other lifestyle habits.

  Day 1

• Determine the degree of knowledge among patients diagnosed with breast cancer regarding the minimum recommended level of physical activity according to international guidelines.

  Day 1

Study Arms (1)

Experimental group

Self-administered questionnaire only once

Behavioral: Questionnaire

Interventions

Questionnaire BEHAVIORAL

Patients access the questionnaire via a link that redirects them to the GEICAM intranet platform, where the questionnaire is hosted. The dissemination of the link is carried out through GEICAM's channels on social media, its website, and the newsletters to our members and patient associations. The dissemination of the link is conducted via GEICAM's channels on social media, GEICAM website, and newsletters for GEICAM members and patient associations. Additionally, information may be provided in paper format with the participation of our associates. The involvement of various national patient associations, with whom GEICAM has collaboration agreements, is expected to encourage the participation of as many patients as possible.

Experimental group

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients with breast cancer at various stages of the disease. Patients access the questionnaire via a link that redirects them to the GEICAM intranet platform, where the questionnaire is hosted. The dissemination of the link is carried out through GEICAM's channels on social media, its website, and las newsletters de nuestros Asociados y a asociaciones de pacientes. The dissemination of the link is conducted via GEICAM's channels on social media, GEICAM website, and newsletters for GEICAM members and patient associations. The involvement of various national patient associations, with whom GEICAM has collaboration agreements, is expected to encourage the participation of as many patients as possible.

You may qualify if:

• Women and men.
• Individuals aged 18 years and over.
• Diagnosis of localized or advanced breast cancer, either undergoing treatment or in follow-up.
• Patients who are able and willing to complete the questionnaires provided for the study.

Sponsors & Collaborators

• Spanish Breast Cancer Research Group: lead

Study Sites (1)

Spanish Breast Cancer Research Group (GEICAM)

San Sebastián de los Reyes, Madrid, 28700, Spain

Location

Related Links

• Spanish Breast Cancer Research Group (GEICAM) is a Multidisciplinary academic group leading in breast cancer research, education, and patient support

MeSH Terms

Conditions

Breast Neoplasms; Motor Activity; Behavior

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Neoplasms by Site; Neoplasms; Breast Diseases; Skin Diseases; Skin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

Data Collection; Epidemiologic Methods; Investigative Techniques; Health Care Evaluation Mechanisms; Quality of Health Care; Health Care Quality, Access, and Evaluation; Public Health; Environment and Public Health

Study Officials

• Study Director Study Director

  Complejo Hospitalario Universitario A Coruña (CHUAC)

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: March 12, 2026
• First Posted: March 18, 2026
• Study Start: January 8, 2025
• Primary Completion: May 31, 2025
• Study Completion: May 31, 2025
• Last Updated: March 20, 2026

Record last verified: 2026-03

Data Sharing

• IPD Sharing: Will not share

Locations

ES (1)